| ￥3800 | |
| Z05538-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | Baculovirus-Insect Cells | ||||
| Theoretical Molecular Weight | 57.33 kDa | ||||
| Apparent Molecular Weight | The protein has a predicted MW of 57.33 kDa same as Bis-Tris PAGE result. | ||||
| Formulation | Supplied as 0.22 μm filtered solution in 50mM Tris, 150mM NaCl, 25% glycerol, 0.5mM PMSF, 0.5 mM TCEP, 0.1mM EDTA, 0.5mM GSH (pH 7.5). | ||||
| Concentration | Verified by one or more methods from 0.64mg/ml A280/Bioactivity/BCA/Bradford. | ||||
| Storage & Stability | This product remains stable for 6 months at -80°C or below. Avoid repeated freeze-thaw cycles. |
| Target Background | Itk/Emt, a tec family tyrosine kinase, is important for T-cell development and activation through the antigen receptor. Itk/Emt can induce the generation of important second signals (PKC, Ca2+) and can modulate their duration by maintaining the stability of scaffolding complexes through regulation of cytoskeletal reorganization. |
| Synonyms | Kinase EMT; ITK; EMT; LYK; T-cell-specific kinase; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
